Iraq vs Pakistan: Death rate from cancer
Iraq
49.64 deaths per 100,000 people
in 2021
Pakistan
49.61 deaths per 100,000 people
in 2021
Iraq rank
146th
Pakistan rank
148th
Death rate from cancer over time
- Iraq
- Pakistan
How they compare
Iraq currently reports 49.64 deaths per 100,000 people against 49.61 deaths per 100,000 people in Pakistan, a difference of 0.03 deaths per 100,000 people.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Pakistan ahead.
Iraq ranks 146th and Pakistan ranks 148th of 194 countries.
Pakistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.92 deaths per 100,000 people | 52.64 deaths per 100,000 people | 4.72 deaths per 100,000 people | Pakistan |
| 2010s | 51.93 deaths per 100,000 people | 53.62 deaths per 100,000 people | 1.69 deaths per 100,000 people | Pakistan |
| 2020s | 49.76 deaths per 100,000 people | 50.13 deaths per 100,000 people | 0.375 deaths per 100,000 people | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Iraq or Pakistan?
- Iraq, at 49.64 deaths per 100,000 people against 49.61 deaths per 100,000 people in Pakistan as of 2021.
- What is the difference in death rate from cancer between Iraq and Pakistan?
- 0.03 deaths per 100,000 people, with Iraq ahead.
- How many years of comparable data are there for Iraq and Pakistan?
- 22 years are reported by both, from 2000 to 2021.
- How do Iraq and Pakistan rank globally for death rate from cancer?
- Iraq ranks 146th and Pakistan ranks 148th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.